Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Economic Report Haiti.
Press releases published on April 30, 2025
HII Declares Quarterly Dividend
GlobeNewswire
·
April 30, 2025
NEWPORT NEWS, Va., April 30, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.35 per share, payable on June 13, 2025, to shareholders of record as of the close of business on …
Genius Group Announces 2024 Financial Results, 303% NAV Growth
GlobeNewswire
·
April 30, 2025
Increase in Net Asset Value (NAV) to $79.4 million from $19.7 million in 2023. SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, …
Kneat to Announce 2025 First-Quarter Financial Results May 7, 2025
GlobeNewswire
·
April 30, 2025
LIMERICK, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial …
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
GlobeNewswire
·
April 30, 2025
— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage biopharmaceutical company focused on …
Cellectar Announces Plan to Explore Strategic Alternatives
GlobeNewswire
·
April 30, 2025
FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today …
SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time
GlobeNewswire
·
April 30, 2025
DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced …
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
GlobeNewswire
·
April 30, 2025
CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Folia Health and Inspire are Partnering to Bring Personalized Home Health Observations to the Forefront of Patient Focused Drug Development Research
GlobeNewswire
·
April 30, 2025
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Folia Health, the pioneer of patient-driven Home Reported Outcomes (HRO), has partnered with Inspire, the world's leading online health community and real-world data platform, to uniquely empower patients and …
Tow4Tech Raises $1.5M Pre-Seed Round to Modernize Commercial Fleet Towing, Backed by BrightCap Ventures
GlobeNewswire
·
April 30, 2025
CORAL SPRINGS, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Tow4Tech, an innovative SaaS-based platform revolutionizing the $12 billion commercial-fleet towing industry, today announced it has raised $1.5 million in pre-seed funding. The round was led by …
Voxtur Announces Financial Results for the Year and Quarter Ended December 31, 2024
GlobeNewswire
·
April 30, 2025
TORONTO and TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today …
BioAtla to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …
QKS Group Eyes a Global Top 5 Spot in the Analyst Industry
GlobeNewswire
·
April 30, 2025
Middleton, Massachusetts, April 30, 2025 (GLOBE NEWSWIRE) -- The world of technology research and advisory is entering a new era, and it is experiencing fluctuations that are not just visible on paper, but in how the game is played. Firms using traditional …
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences: Event: BofA …
Solid Biosciences to Participate at The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, …
Valitor to Present on its Drug Candidate with Twice-Yearly Dosing for Wet AMD at the American Academy of Ophthalmology’s Eyecelerator Conference and the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
GlobeNewswire
·
April 30, 2025
BERKELEY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its president and chief scientific officer, Wesley Jackson, Ph.D., will present a company and …
Global-e to Announce Financial Results for the First Quarter 2025 on May 14, 2025
GlobeNewswire
·
April 30, 2025
PETAH-TIKVA, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the first quarter ended March 31, 2025, before …
Greenridge Exploration Completes Airborne MobileMT Survey at the Sabre Uranium Project in Athabasca Basin, Saskatchewan
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: HW3 | OTCQB: GXPLF) is pleased to announce the completion of a high-resolution helicopter-borne Mobile …
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
GlobeNewswire
·
April 30, 2025
WEST CHESTER, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced …
NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress
GlobeNewswire
·
April 30, 2025
NAARDEN, the Netherlands and MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …
Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor
GlobeNewswire
·
April 30, 2025
SALT LAKE CITY, April 30, 2025 (GLOBE NEWSWIRE) -- Nearly nine out of ten (89%) Americans diagnosed with depression and/or anxiety believe mental health medications are somewhat or very effective, yet concerns about potential side effects remain a …